GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (NAS:RKDA) » Definitions » E10

Arcadia Biosciences (Arcadia Biosciences) E10 : $-264.74 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Arcadia Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was $-1.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-264.74 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-19), Arcadia Biosciences's current stock price is $3.05. Arcadia Biosciences's E10 for the quarter that ended in Mar. 2024 was $-264.74. Arcadia Biosciences's Shiller PE Ratio of today is .


Arcadia Biosciences E10 Historical Data

The historical data trend for Arcadia Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences E10 Chart

Arcadia Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -270.87

Arcadia Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -289.80 -285.37 -280.86 -270.87 -264.74

Competitive Comparison of Arcadia Biosciences's E10

For the Packaged Foods subindustry, Arcadia Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Shiller PE Ratio falls into.



Arcadia Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcadia Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.78/131.7762*131.7762
=-1.780

Current CPI (Mar. 2024) = 131.7762.

Arcadia Biosciences Quarterly Data

per share eps CPI Adj_EPS
201406 -154.743 100.560 -202.780
201409 -211.100 100.428 -276.995
201412 -88.949 99.070 -118.314
201503 -161.847 99.621 -214.087
201506 -152.000 100.684 -198.939
201509 -88.000 100.392 -115.511
201512 -72.000 99.792 -95.076
201603 -96.000 100.470 -125.913
201606 -80.000 101.688 -103.671
201609 -72.000 101.861 -93.145
201612 -106.000 101.863 -137.128
201703 -76.000 102.862 -97.363
201706 -75.200 103.349 -95.884
201709 -84.800 104.136 -107.308
201712 -55.600 104.011 -70.442
201803 -194.400 105.290 -243.303
201806 -80.800 106.317 -100.149
201809 37.200 106.507 46.026
201812 6.400 105.998 7.956
201903 -105.600 107.251 -129.748
201906 33.600 108.070 40.971
201909 -81.600 108.329 -99.261
201912 -20.000 108.420 -24.308
202003 11.600 108.902 14.037
202006 -41.600 108.767 -50.400
202009 -24.000 109.815 -28.800
202012 38.000 109.897 45.565
202103 4.400 111.754 5.188
202106 -9.600 114.631 -11.036
202109 -4.000 115.734 -4.554
202112 -17.160 117.630 -19.224
202203 -8.090 121.301 -8.789
202206 -6.810 125.017 -7.178
202209 -4.670 125.227 -4.914
202212 -6.280 125.222 -6.609
202303 -10.860 127.348 -11.238
202306 0.610 128.729 0.624
202309 -1.890 129.860 -1.918
202312 -1.990 129.419 -2.026
202403 -1.780 131.776 -1.780

Add all the adjusted EPS together and divide 10 will get our e10.


Arcadia Biosciences  (NAS:RKDA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Arcadia Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcadia Biosciences (Arcadia Biosciences) Business Description

Traded in Other Exchanges
Address
5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.
Executives
Thomas J. Schaefer officer: Chief Financial Officer 202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Stanley Jr Jacot officer: Chief Executive Officer 202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Pamela Haley officer: Chief Financial Officer 202 COUSTEAU PLACE, DAVIS CA 95618
Laura Pitlik officer: Chief Marketing Officer 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Chris Cuvelier officer: Chief Growth Officer 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Deborah D Carosella director 3603 HAVEN AVE, SUITE E, MENLO PARK CA 94025
Matthew T Plavan officer: Chief Financial Officer C/O THERMOGENESIS CORP., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Randall Shultz officer: Chief Technology Officer 4222 E. THOMAS ROAD, SUITE 320, PHOEBIIX AZ 85018
Sarah Reiter officer: Chief Commercial Officer 202 COUSTEAU PLACE, DAVIS CA 95618
Lilian Shackelford Murray director 228 BEACH ROAD, BELVEDERE CA 94920
Kevin Comcowich director C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
Eric J. Rey director, officer: President and CEO ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Zhongjin Lu officer: VP Product Development ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Amy Yoder director C/O SPECTRUM BRANDS, INC., 6 CONCOURSE PARKWAY, SUITE 3300, ATLANTA GA 30328